NGM Biopharmaceuticals Volatility
| NGMDelisted Stock | USD 2.50 0.14 5.30% |
We have found twenty-three technical indicators for NGM Biopharmaceutica, which you can use to evaluate the volatility of the firm. Please verify NGM Biopharmaceutica's risk adjusted performance of (0.08), and Mean Deviation of 3.76 to check out if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to NGM Biopharmaceutica's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
NGM Biopharmaceutica Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of NGM daily returns, and it is calculated using variance and standard deviation. We also use NGM's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of NGM Biopharmaceutica volatility.
NGM |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as NGM Biopharmaceutica can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of NGM Biopharmaceutica at lower prices. For example, an investor can purchase NGM stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of NGM Biopharmaceutica's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving together with NGM Stock
| 0.64 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.72 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.77 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.67 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against NGM Stock
| 0.84 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.83 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.81 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.8 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.79 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.77 | WMT | Walmart Aggressive Push | PairCorr |
| 0.76 | T | ATT Inc Aggressive Push | PairCorr |
| 0.75 | PTAIF | PT Astra International | PairCorr |
| 0.71 | HD | Home Depot Sell-off Trend | PairCorr |
NGM Biopharmaceutica Market Sensitivity And Downside Risk
NGM Biopharmaceutica's beta coefficient measures the volatility of NGM stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents NGM stock's returns against your selected market. In other words, NGM Biopharmaceutica's beta of 0.65 provides an investor with an approximation of how much risk NGM Biopharmaceutica stock can potentially add to one of your existing portfolios. NGM Biopharmaceuticals exhibits very low volatility with skewness of -0.67 and kurtosis of 1.07. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure NGM Biopharmaceutica's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact NGM Biopharmaceutica's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze NGM Biopharmaceuticals Demand TrendCheck current 90 days NGM Biopharmaceutica correlation with market (Dow Jones Industrial)NGM Beta |
NGM standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by NGM Biopharmaceutica's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of NGM Biopharmaceutica's daily returns or price. Since the actual investment returns on holding a position in ngm stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in NGM Biopharmaceutica.
NGM Biopharmaceuticals Stock Volatility Analysis
Volatility refers to the frequency at which NGM Biopharmaceutica delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with NGM Biopharmaceutica's price changes. Investors will then calculate the volatility of NGM Biopharmaceutica's stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of NGM Biopharmaceutica's volatility:
Historical Volatility
This type of delisted stock volatility measures NGM Biopharmaceutica's fluctuations based on previous trends. It's commonly used to predict NGM Biopharmaceutica's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for NGM Biopharmaceutica's current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on NGM Biopharmaceutica's to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
NGM Biopharmaceutica Projected Return Density Against Market
Considering the 90-day investment horizon NGM Biopharmaceutica has a beta of 0.6467 . This indicates as returns on the market go up, NGM Biopharmaceutica average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding NGM Biopharmaceuticals will be expected to be much smaller as well.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to NGM Biopharmaceutica or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that NGM Biopharmaceutica's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a NGM delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
NGM Biopharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a NGM Biopharmaceutica Price Volatility?
Several factors can influence a delisted stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.NGM Biopharmaceutica Stock Return Volatility
NGM Biopharmaceutica historical daily return volatility represents how much of NGM Biopharmaceutica delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm has volatility of 0.0% on return distribution over 90 days investment horizon. By contrast, Dow Jones Industrial accepts 0.7777% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About NGM Biopharmaceutica Volatility
Volatility is a rate at which the price of NGM Biopharmaceutica or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of NGM Biopharmaceutica may increase or decrease. In other words, similar to NGM's beta indicator, it measures the risk of NGM Biopharmaceutica and helps estimate the fluctuations that may happen in a short period of time. So if prices of NGM Biopharmaceutica fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California. Ngm Biopharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people.
NGM Biopharmaceutica's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on NGM Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much NGM Biopharmaceutica's price varies over time.
3 ways to utilize NGM Biopharmaceutica's volatility to invest better
Higher NGM Biopharmaceutica's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of NGM Biopharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. NGM Biopharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of NGM Biopharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in NGM Biopharmaceutica's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of NGM Biopharmaceutica's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
NGM Biopharmaceutica Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.78 and is 9.223372036854776E16 times more volatile than NGM Biopharmaceuticals. Compared to the overall equity markets, volatility of historical daily returns of NGM Biopharmaceuticals is lower than 0 percent of all global equities and portfolios over the last 90 days. You can use NGM Biopharmaceuticals to protect your portfolios against small market fluctuations. The stock experiences a very speculative upward sentiment. Check odds of NGM Biopharmaceutica to be traded at $2.38 in 90 days.Average diversification
The correlation between NGM Biopharmaceuticals and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NGM Biopharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
NGM Biopharmaceutica Additional Risk Indicators
The analysis of NGM Biopharmaceutica's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in NGM Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some common measures of NGM Biopharmaceutica stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.94) | |||
| Mean Deviation | 3.76 | |||
| Coefficient Of Variation | (825.03) | |||
| Standard Deviation | 4.97 | |||
| Variance | 24.72 | |||
| Information Ratio | (0.15) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
NGM Biopharmaceutica Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against NGM Biopharmaceutica as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. NGM Biopharmaceutica's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, NGM Biopharmaceutica's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to NGM Biopharmaceuticals.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in NGM Stock
If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |